Mujie Li
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Renal and related cancers 8
- Extracellular vesicles in disease 4
- Chromatin Remodeling and Cancer 3
-
- Renal cell carcinoma treatment 5
- Co-authors
- Jinkui Wang (24 shared papers)Zhaoxia Zhang (24 shared papers)Tao Mi (23 shared papers)Liming Jin (23 shared papers)Chenghao Zhanghuang (17 shared papers)Dawei He (20 shared papers)Zhongjun Ma (1 shared paper)Yue Hou (1 shared paper)
- Journals
- Frontiers in Public Health (5 papers)European Journal of Pharmacology (2 papers)Cancers (2 papers)Frontiers in Oncology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Mujie Li
33 papers receiving 423 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 78
- Endocrinology 22
- Molecular Biology 245
- Health Informatics 3
- Pulmonary and Respiratory Medicine 71
Countries citing papers authored by Mujie Li
This map shows the geographic impact of Mujie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mujie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mujie Li more than expected).
Fields of papers citing papers by Mujie Li
This network shows the impact of papers produced by Mujie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mujie Li. The network helps show where Mujie Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mujie Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 81 | |
| 2 | 2022 | 53 | |
| 3 | 2022 | 45 | |
| 4 | 2013 | 38 | |
| 5 | 2011 | 26 | |
| 6 | 2022 | 24 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2014 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Mujie Li
Mujie Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 34 papers that have together received 427 indexed citations. Recurring topics across this work include Renal and related cancers (8 papers), Renal cell carcinoma treatment (5 papers), Neuroblastoma Research and Treatments (4 papers), MicroRNA in disease regulation (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Extracellular vesicles in disease (4 papers), Chromatin Remodeling and Cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (78 citations), Endocrinology (22 citations), Molecular Biology (245 citations), Health Informatics (3 citations) and Pulmonary and Respiratory Medicine (71 citations). Mujie Li has collaborated with scholars based in China and United States. Frequent co-authors include Jinkui Wang, Zhaoxia Zhang, Tao Mi, Liming Jin, Chenghao Zhanghuang, Dawei He, Zhongjun Ma, Yue Hou, Ning Li and Mingzhou Zhang. Their work appears in journals such as Frontiers in Public Health, European Journal of Pharmacology, Cancers, Frontiers in Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.